retatrutide drug trial Eli Lilly infiltrates anti-obesity market as Phase III for begins Retatrutide Dosing Guide: 1-12 mg

A primary concern for menopausal GLP-1 users is the potential for accelerated bone thinning and muscle loss, which is why experts emphasize the necessity of a high protein intake and consistent strength training to mitigate these risks

Bush Hoffmann U, Fischereder M, Kruger B, Drobnik W, Kramer BK

Meaning If confirmed by clinical trials, GLP-1 RAs show promise as chemopreventive agents for cirrhosis and its complications in patients with MASLD and diabetes

Clinical trials of GLP-1-based therapies commonly exclude individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) on the basis of preclinical thyroid C-cell findings

The results might even have you skipping your filter